Piramal Enterprises Ltd

I won’t read too much into it, without any solid evidence. I feel it is a post special situation playing out and Mr. Market offering an opportunity. Among demerged entities, from what i know, most people were interested in the Pharma piece and not the Financial piece. So they may be offloading the Financial part. At around 0.5 P/B, any incremental risk in the book is already factored in (no evidence to that effect as of now) and i feel it is a good price to enter. Also, any capital inflow due to Sriram stake sale will be a big additional booster to the book value
Disclaimer – Invested and hence may be biased